Ronda Edgley
Nurse Practitioner · Pocatello, IDNPI 1902456262
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 182 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 21 manufacturers reported payments, led by AbbVie at 37.3% of the total. Reporting peaked in 2024 at $1,473 and has fallen 74.3% since, to $379 in 2025. Among nurse practitioner clinicians in ID with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 182 payments — averaging $16.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$621
- Teva Pharmaceuticals USA, Inc.$474
- Alkermes, Inc.$124
- Axsome Therapeutics, Inc.$117
- Boston Scientific$63
- plus $464 from 15 others
What the payments were for
- Food & beverage$2,970100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 69 | $1,107 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 37 | $621 |
| Teva Pharmaceuticals USA, Inc. | 34 | $474 |
| Alkermes, Inc. | 7 | $124 |
| Axsome Therapeutics, Inc. | 6 | $117 |
| Boston Scientific | 4 | $63 |
| Otsuka America Pharmaceutical, Inc. | 3 | $60 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $53 |
| Tris Pharma Inc | 3 | $52 |
| E.r. Squibb & Sons, L.L.C. | 2 | $38 |
| Johnson & Johnson | 2 | $35 |
| Pfizer | 2 | $33 |
| Bristol Myers Squibb | 1 | $33 |
| Corium, LLC | 2 | $27 |
| Cardiva Medical, Inc. | 1 | $24 |
| Novartis | 1 | $24 |
| Ironshore Pharmaceuticals Inc. | 1 | $22 |
| Vanda Pharmaceuticals Inc. | 1 | $17 |
| Lilly USA, LLC | 1 | $17 |
| Lundbeck LLC | 1 | $16 |
| Neurocrine Biosciences, Inc. | 1 | $15 |
How this compares
$2,970 in reported general payments places this provider in the 90th percentile of 570 nurse practitioner providers in Idaho.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dicyclomine Hcl | 11 | $284 |
| Levothyroxine Sodium | 36 | $189 |
| Omeprazole | 17 | $40 |
| Metoprolol Tartrate | 12 | $29 |
Paid to pharmacies, not to this prescriber.
Other nurse practitioner in Pocatello
- Hanna PercyPocatello$6K
- Cynthia RicePocatello$3K
- Kathleen CliffordBoise$119K
- Alissa HelvikCoeur D Alene$93K
- Amanda ThompsonIdaho Falls$67K
- Micalena PerkinsBurley$44K
- Tosha JohnsonNampa$26K
- Loreen NugentBoise$20K
- Rachel RyanMeridian$19K
- Stephanie HartPost Falls$18K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.